Latest AI and machine learning research in endocrinology for healthcare professionals.
Artificial Intelligence (AI) has evolved through various trends, with different subfields gaining prominence over time. Currently, Conversational Artificial Intelligence (CAI)—particularly Generative AI—is at the forefront. CAI models are primarily focused on text-based tasks and are commonly deployed as chatbots. Recent advancements by OpenAI have enabled the integration of external, independentl...
Synthetic data generated using generative models trained on real clinical data offers a promising solution to privacy concerns in health research. However, many efforts are limited by small or demographically narrow training datasets, reducing the generalizability of the synthetic data. To address this, we used real-world clinical data from nearly one million individuals with diabetes in the Andal...
Large language models (LLMs) have fundamentally changed how patients and clinicians retrieve information; however, it is unclear how accurate and cons...
Brain tumor classification using MRI scans is crucial for early diagnosis and treatment planning. In this study, we first train a single Convolutional...
The VISION study1 found that Lutetium-177 (177Lu)–PSMA-617 (“Lu-177”) improved overall survival in metastatic castrate resistant prostate cancer (mCRP...
Weight gain is a common side effect in patients treated with olanzapine (N05AH03), contributing to increased risks of metabolic complications such as ...
Diabetes-related foot ulcers (DFUs) are a serious complication of diabetes, often resulting in infection, amputation, or even mortality. Offloading fo...
Small open-source medical large language models (LLMs) offer promising opportunities for low-resource deployment and broader accessibility. However, t...
Deep learning models applied to digital histology can predict gene expression signatures (GES) and offer a low-cost, rapidly available alternative to ...
White adipose tissue dysfunction has emerged as a critical factor in cardiometabolic disease development, yet the cellular microstructure and genetic ...
For accurate medication usage statistics and medication adherence calculations, we need to have an accurate days’ supply (DS) for each prescription. U...
Early diabetes detection remains challenging, requiring robust machine learning approaches that balance accuracy with clinical interpretability for ef...
This study evaluated the prognostic performance of RlapsRisk BC, a multimodal deep learning tool designed to predict distant recurrence-free interval ...
Real-world adoption of closed-loop insulin delivery systems (CLIDS) in type 1 diabetes remains low, driven not by technical failure, but by diverse be...
Cardiovascular-kidney-metabolic (CKM) syndrome is a newly defined multisystem disease continuum characterized by the coexistence of metabolic dysfunct...
Diabetes, hypertension, and dyslipidemia are major risk factors for cardiovascular (CVD), cerebral, and renal diseases (RD). However, the underlying m...
Deep learning models for the screening of diabetic retinopathy (DR) have achieved near-human performance on benchmark datasets, but their performance ...
Gestational diabetes mellitus (GDM) affects 15.6% of pregnancies globally, with Vietnam exhibiting one of the highest prevalences at 21%. Current diag...
Type 2 diabetes mellitus (T2DM) affects almost half a billion people, and the projected cost is $2.25 trillion by 2030; early detection strategies are...
To develop and evaluate a novel self-supervised learning approach using Masked Autoencoder (MAE) pre-trained Vision Transformer (ViT) for automated de...